tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN
US Market
Holding LPCN?
Track your performance easily

Lipocine (LPCN) Technical Analysis

884 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Lipocine’s (LPCN) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Lipocine is a Buy.
Lipocine’s (LPCN) 20-Day exponential moving average is 4.62, while Lipocine’s (LPCN) share price is $4.32, making it a Sell.
Lipocine’s (LPCN) 50-Day exponential moving average is 4.78, while Lipocine’s (LPCN) share price is $4.32, making it a Sell.

Lipocine (LPCN) Pivot Points

Feb 02, 2025, 12:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.32
4.39
4.43
4.51
4.55
4.62
4.66
Fibonacci
4.39
4.44
4.46
4.51
4.55
4.58
4.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lipocine (LPCN) Moving Averages

Feb 02, 2025, 12:14 AM
Period
Simple
Exponential
MA5
4.48Sell
4.45Sell
MA10
4.50Sell
4.52Sell
MA20
4.68Sell
4.62Sell
MA50
4.79Sell
4.78Sell
MA100
4.91Sell
4.89Sell
MA200
5.37Sell
5.08Sell
Lipocine’s (LPCN) 10-Day exponential moving average is 4.52, while Lipocine’s (LPCN) share price is $4.32, making it a Sell.
Lipocine’s (LPCN) 100-Day exponential moving average is 4.89, while Lipocine’s (LPCN) share price is $4.32, making it a Sell.
Lipocine’s (LPCN) stock price is $4.32 and Lipocine’s (LPCN) 50-day simple moving average is 4.79, creating a Sell signal.
Lipocine’s (LPCN) stock price is $4.32 and Lipocine’s (LPCN) 100-day simple moving average is 4.91, creating a Sell signal.
Lipocine’s (LPCN) stock price is $4.32 and Lipocine’s (LPCN) 200-day simple moving average is 5.37, creating a Sell signal.

Lipocine (LPCN) Technical Indicators

Feb 02, 2025, 12:14 AM
Name
Value
Implied Action
RSI (14)
40.39
Neutral
STOCH (9,6)
19.33
Buy
STOCHRSI (14)
17.99
Buy
MACD (12,26)
-0.12
Buy
ADX (14)
10.73
Buy
Williams %R
-91.72
Buy
CCI (14)
-106.82
Buy
ATR (14)
0.33
-
Ultimate Oscillator
29.86
Sell
ROC
-11.66
Sell
Lipocine’s (LPCN) Relative Strength Index (RSI) is 40.39, creating a Neutral signal.
Lipocine’s (LPCN) Trend Strength Indicator (ADX) is 10.73, creating a Buy signal.
Lipocine’s (LPCN) Commodity Channel Index (CCI) is -106.82, creating a Buy signal.
Lipocine’s (LPCN) Price Rate of Change (ROC) is -11.66, creating a Sell signal.

FAQ

Is LPCN a Buy, Hold, or Sell?
Based on LPCN’s technical indicators, LPCN is a Sell.
    What is LPCN’s RSI (14)?
    LPCN’s RSI (14) is 40.39, which suggests LPCN is a Neutral.
      What is LPCN’s MACD?
      LPCN’s MACD is -0.12, which suggests LPCN is a Buy.
        What is LPCN’s 5-day moving average?
        LPCN’s 5-day moving average is 4.48, which suggests LPCN is a Sell.
          What is LPCN’s 20-day moving average?
          LPCN 20-day moving average is 4.68, which suggests LPCN is a Sell.
            What is LPCN’s 50-day moving average?
            LPCN’s 50-day moving average is 4.79, which suggests LPCN is a Sell.
              What is LPCN’s 200-day moving average?
              LPCN’s 200-day moving average is 5.37, which suggests LPCN is a Sell.
                What is LPCN’s Williams % R (14)?
                LPCN’s Williams % R (14) is -91.72, which suggests LPCN is a Buy.
                  What is LPCN’s CCI (14)?
                  LPCN’s CCI (14) is -106.82, which suggests LPCN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis